Literature DB >> 15492200

Efficacy and safety of 5% imiquimod cream in treating patients with multiple superficial basal cell carcinomas.

Robin Marks, Mary Owens, Shelley-Ann Walters.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15492200     DOI： 10.1001/archderm.140.10.1284-b

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN： 0003-987X


× No keyword cloud information.
  5 in total

Review 1.  [Therapeutic options for epithelial skin tumors. Actinic keratoses, Bowen disease, squamous cell carcinoma, and basal cell carcinoma].

Authors:  R-M Szeimies; S Karrer; H Bäcker
Journal:  Hautarzt       Date:  2005-05       Impact factor: 0.751

2.  Large superficial Basal cell carcinoma arising in the scalp.

Authors:  Min Soo Jang; Jae Woo Baek; Jong Bin Park; Dong Young Kang; Jin Seuk Kang; Kee Suck Suh; Sang Tae Kim
Journal:  Ann Dermatol       Date:  2011-09-30       Impact factor: 1.444

3.  Engaging Pattern Recognition Receptors in Solid Tumors to Generate Systemic Antitumor Immunity.

Authors:  Michael Brown
Journal:  Cancer Treat Res       Date:  2022

Review 4.  Pharmacological treatments for basal cell carcinoma.

Authors:  Seongmu Lee; Dinesh Selva; Shyamala C Huilgol; Robert A Goldberg; Igal Leibovitch
Journal:  Drugs       Date:  2007       Impact factor: 9.546

5.  Trial watch: FDA-approved Toll-like receptor agonists for cancer therapy.

Authors:  Erika Vacchelli; Lorenzo Galluzzi; Alexander Eggermont; Wolf Hervé Fridman; Jerome Galon; Catherine Sautès-Fridman; Eric Tartour; Laurence Zitvogel; Guido Kroemer
Journal:  Oncoimmunology       Date:  2012-09-01       Impact factor: 8.110
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.